文献速递皮肤肿瘤

共享医师的区域退伍军人事务中心与三级医疗中心黑色素瘤结局差异:队列研究

Differential melanoma outcomes in a regional Veterans Affairs center and a tertiary care center with shared physician staffing: A cohort study.
PubMed 文献 · J Am Acad Dermatol · 2026-07-08

该回顾性队列研究比较了共享医师的退伍军人事务(VA)中心与附近三级医疗中心的黑色素瘤患者结局。VA患者年龄更大且原位黑色素瘤比例更高(P < .0001)。VA男性局限性黑色素瘤的特异性生存优于三级中心男性(P = .003),但区域性疾病(P = .0002)和远处疾病(P = .02)生存更差;与三级中心VA参保男性相比,VA男性局限性病变生存仍更优(P < .0001),但区域或远处病变差异不再显著。三级中心内,公共保险患者黑色素瘤特异性死亡率高于私人保险(Medicare HR 1.46 [1.22-1.75];Medicaid 1.67 [1.28-2.18];Military/VA 1.92 [1.15-3.20])。

要点

  • VA男性局限性黑色素瘤特异性生存优于三级中心男性。
  • VA男性区域性和远处黑色素瘤生存较三级中心男性更差。
  • 三级中心内公共保险与黑色素瘤特异性死亡率增加相关。

核心结论

  • 预防性筛查和选择性转诊的差异可能促成VA早期黑色素瘤生存增加。
  • 机构内外保险类型与晚期黑色素瘤死亡率差异相关,提示需进一步标准化诊疗。

研究设计与样本

  • 回顾性队列研究,纳入1987年1月至2023年5月在共享医师的VA中心及附近三级中心就诊的黑色素瘤患者。
  • VA患者638例(男性612例),三级中心患者9682例(男性5564例)。
  • 结局包括黑色素瘤特异性生存和死亡率。

主要发现

  • VA患者年龄更大且原位黑色素瘤比例更高(P < .0001)。
  • VA男性与三级中心男性相比:局限性黑色素瘤特异性生存增加(P = .003),区域性疾病降低(P = .0002),远处疾病降低(P = .02)。
  • VA男性与三级中心VA参保男性相比:局限性病变生存仍增加(P < .0001),区域或远处病变差异不再显著。
  • 三级中心内公共保险患者黑色素瘤特异性死亡率高于私人保险:Medicare HR 1.46(95%CI 1.22-1.75);Medicaid HR 1.67(95%CI 1.28-2.18);Military/VA HR 1.92(95%CI 1.15-3.20)。

临床怎么用

  • 关注早期黑色素瘤的预防性筛查可能改善生存。
  • 晚期黑色素瘤需注意保险类型相关的诊疗差异并推动标准化。

局限性

  • VA参保患者数量较少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Melanoma outcomes vary by subgroups. OBJECTIVE: Identify institutional/systemic factors contributing to outcome differences. METHODS: Retrospective cohort study of melanoma patients seen from January 1987 to May 2023 at a Veterans Affairs (VA) center and nearby tertiary care center sharing providers. Outcomes include melanoma-specific survival and mortality. RESULTS: Compared to the tertiary center (n = 9,682, 5564 males), VA patients (n = 638, 612 males) were older and had a greater proportion of melanoma in situ (P < .0001). When comparing VA males to males treated at the tertiary center, melanoma-specific survival was increased for localized melanoma (P = .003) but decreased for regional (P = .0002) and distant disease (P = .02). When comparing VA males to VA-insured males at the tertiary center, melanoma-specific survival remained increased for localized disease (P < .0001), but differences for regional or distant disease were no longer significant. Within the tertiary center, publicly insured patients had increased melanoma-specific mortality compared to privately insured (Medicare, hazard ratio [95% confidence interval]: 1.46 [1.22-1.75]; Medicaid, 1.67 [1.28-2.18]; Military/VA 1.92 [1.15-3.20]). LIMITATIONS: Smaller number of VA-insured patients. CONCLUSION: Differences in preventative screening and selective referrals may contribute to increased survival at the VA for early-stage melanoma. Insurance type within and between institutions is associated with differential mortality outcomes for advanced melanoma stages, indicating a need for additional care standardization.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Chen J, Fernandez K, Tang AS, et al. Differential melanoma outcomes in a regional Veterans Affairs center and a tertiary care center with shared physician staffing: A cohort study. J Am Acad Dermatol. 2026. PMID: 42419594. doi:10.1016/j.jaad.2026.07.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。